1. Home
  2. EARN vs BWAY Comparison

EARN vs BWAY Comparison

Compare EARN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • BWAY
  • Stock Information
  • Founded
  • EARN 2012
  • BWAY 2003
  • Country
  • EARN United States
  • BWAY Israel
  • Employees
  • EARN 160
  • BWAY N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • BWAY Medical/Dental Instruments
  • Sector
  • EARN Real Estate
  • BWAY Health Care
  • Exchange
  • EARN Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • EARN 189.7M
  • BWAY 280.7M
  • IPO Year
  • EARN 2013
  • BWAY 2019
  • Fundamental
  • Price
  • EARN $5.15
  • BWAY $15.50
  • Analyst Decision
  • EARN Buy
  • BWAY Strong Buy
  • Analyst Count
  • EARN 2
  • BWAY 2
  • Target Price
  • EARN $5.88
  • BWAY $18.00
  • AVG Volume (30 Days)
  • EARN 339.3K
  • BWAY 50.6K
  • Earning Date
  • EARN 11-11-2025
  • BWAY 11-11-2025
  • Dividend Yield
  • EARN 18.80%
  • BWAY N/A
  • EPS Growth
  • EARN N/A
  • BWAY 679.98
  • EPS
  • EARN N/A
  • BWAY 0.11
  • Revenue
  • EARN $35,893,000.00
  • BWAY $46,084,000.00
  • Revenue This Year
  • EARN N/A
  • BWAY $335.63
  • Revenue Next Year
  • EARN $15.96
  • BWAY $22.10
  • P/E Ratio
  • EARN N/A
  • BWAY $54.26
  • Revenue Growth
  • EARN 43.30
  • BWAY 26.50
  • 52 Week Low
  • EARN $4.33
  • BWAY $7.84
  • 52 Week High
  • EARN $7.11
  • BWAY $17.00
  • Technical
  • Relative Strength Index (RSI)
  • EARN 35.83
  • BWAY 53.24
  • Support Level
  • EARN $5.01
  • BWAY $14.55
  • Resistance Level
  • EARN $5.13
  • BWAY $16.29
  • Average True Range (ATR)
  • EARN 0.12
  • BWAY 0.72
  • MACD
  • EARN -0.02
  • BWAY 0.00
  • Stochastic Oscillator
  • EARN 20.00
  • BWAY 54.59

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: